HighTide Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 11, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	189	84	854	-	-
Market Cap Growth	139.75%	-90.14%	-	-	-
Enterprise Value	147	9	1,027	-	-
PB Ratio	3.67	1.45	8.62	-	-
P/TBV Ratio	4.28	1.45	8.62	-	-
Debt / Equity Ratio	0.27	0.18	0.02	-2.70	-3.72
Quick Ratio	3.03	4.56	9.43	0.64	26.97
Current Ratio	3.44	4.67	9.76	0.65	27.17
Return on Equity (ROE)	-62.13%	-67.76%	-808.89%	-	-
Return on Assets (ROA)	-35.29%	-41.03%	-33.94%	-17.29%	-
Return on Capital Employed (ROCE)	-85.20%	-98.80%	-62.70%	48.70%	-17.60%
Earnings Yield	-21.55%	-62.15%	-15.51%	-	-
FCF Yield	-17.69%	-49.28%	-5.90%	-	-
Buyback Yield / Dilution	-26.18%	-74.08%	-1.91%	-506.17%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.